C. Bailey
Endocrinology, Diabetes and Metabolism · Diabetologia · 2010–2020
A researcher in the Science corpus: 7 papers; trusts 3 researchers and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Endocrinology, Diabetes and Metabolism — 49 citations into it; #166 of 623 by trust here, #278 by citations
- Physiology — 29 citations into it
- Surgery — 26 citations into it
Whom C. Bailey trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts C. Bailey overall
Papers from C. Bailey's perspective
Ordered by how strongly the researchers C. Bailey trusts endorse each paper. Same corpus, a different order for every researcher.
- Metformin and reduced risk of cancer in diabetic patients (British medical journal)
- Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase (Nature)
- A metagenome-wide association study of gut microbiota in type 2 diabetes (Nature)
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity (Proceedings of the National Academy of Sciences of the United States of America)
- Molecular imaging of cancer with positron emission tomography (Nature Reviews. Cancer)
- TGR5-mediated bile acid sensing controls glucose homeostasis. (Cell Metabolism)
- An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice (Gut)
- A Comprehensive Review of Drug–Drug Interactions with Metformin
- Disentangling the effects of type 2 diabetes and metformin on the human gut microbiota
- Microbiota and diabetes: an evolving relationship (Gut)
Their papers
- Metformin and the gastrointestinal tract (2016) — 658 citations
- Metformin: historical overview (2017) — 908 citations
- Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease. (2020) — 853 citations
- Type 2 diabetes in adolescents and young adults. (2018) — 684 citations
- Metformin in patients with type 2 diabetes and kidney disease: a systematic review. (2014) — 609 citations
- Oral Antidiabetic Agents (2012) — 608 citations
- Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. (2010) — 875 citations